CZP 200 mg every 2 weeks (Q2W) or CZP 400 mg every 4 weeks (Q4W)	placebo	household work days	1394	1511	CZP patients reported an average of 3.0–3.5 household work days gained per month versus 1.0 day for placebo (p<0.05).
CZP 200 mg every 2 weeks (Q2W) or CZP 400 mg every 4 weeks (Q4W)	Placebo	absenteeism and presenteeism	1164	1364	employed CZP patients reported an average of 1.0–1.8 and 3.0–3.9 fewer days of absenteeism and presenteeism, respectively, per month compared with 1.0 and 0.3 fewer days for placebo patients (p<0.05).
CZP 200 mg every 2 weeks (Q2W) or CZP 400 mg every 4 weeks (Q4W)	placebo	household work days	21270	21646	Further improvements were reported in CZP-treated patients up to week 24 with an average of 3.0–3.5 fewer days with no household work, 3.6–4.2 fewer days with reduced household productivity, and PsA interference with productivity within the home reduced by 2.3–3.0, compared with an average of 1.0 less day with no household work per month (p<0.05; either CZP arm vs placebo),
